Skip to main content
OpenTrials
Completed

NCT Number: NCT00960232

Vitamin D, Blood Pressure, Lipids, Infection and Depression

There are numerous indications for a relation between low serum levels of 25(OH)D and blood pressure, lipid levels, frequency of infections and tendency towards depression. Whether it is a causal relationship it is not known, and can best be studied with a vitamin D intervention. The investigators hypothesis is that supplementation with a high dose vitamin D (40.000 IU per week) will have a beneficial effect on these parameters.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of Tromsø

Tromsø, 9037, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • men and women 30 - 75 years of age
  • low serum 25(OH)D levels

Exclusion criteria

  • diabetes
  • other serious diseases
  • hypercalcemia

Treatment and study plan

Cholecalciferol

Drug

40.000 IU cholecalciferol per week for 6 months

Other names: Decristol

Placebo

Drug

placebo

Primary outcomes

  1. Depression score

    Time frame: 6 months

  2. Blood pressure

    Time frame: 6 months

  3. Lipid profile

    Time frame: 6 months

  4. Frequency of infections

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

University of Tromso

Other

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Aug 17, 2009
Registry last updated
Sep 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.